Oventus Medical Ltd

ASX:OVN ISIN:AU000000OVN3

Oventus Medical Ltd (ASX:OVN) is a Brisbane, Australia, based medical device company that is commercialising a new 'Sleep Treatment Platform' for the treatment of sleep apnoea and snoring. The Oventus platform enhances the treatment outcomes of both standard mouthguard-type oral appliance therapy (often used to treat mild to moderate sleep apnoea) and of Continuous Positive Airway Pressure (CPAP) therapy (often used to treat moderate to severe patients.)

Since the Oventus 'Sleep Treatment Platform' is generally well tolerated by patients, and incorporates a unique airway, which supports better breathing, it has been shown in clinical trials to have increased efficacy and provide greater adherence over the competing treatment options.

For more information on Oventus' Sleep Treatment Platform, please visit http://www.oventus.com

       

News

Oventus Medical Ltd (ASX:OVN) Quarterly Business Review - Q4 FY2018

🕔7/24/2018 8:42:47 AM 1050

Oventus Medical Ltd (ASX:OVN) announces its Appendix 4C Report for the three-month period ending 30 June 2018 (Q4 FY2018) and is pleased to provide a review of progress made during the quarter.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Investor Newsletter

🕔6/20/2018 10:17:57 AM 1845

Oventus Medical Ltd (ASX:OVN) is pleased to provide a copy of its latest newsletter for investors.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Innovators in Sleep Apnoea Treatment Presentation for Thorney Investment Forum

🕔5/31/2018 11:29:38 AM 2633

Oventus Medical Ltd (ASX:OVN) is pleased to attach a copy of the presentation that Founder and Clinical Director, Dr Chris Hart will deliver to investors this morning at the Thorney Sydney Investment Forum.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Data Shows O2Vent with New Valve Treats 75% of Patients

🕔5/29/2018 2:09:34 PM 2320

Oventus Medical Ltd (ASX:OVN) is pleased to announce positive interim data being presented today in a lecture at Macquarie University on a group of hard-to-treat obstructive sleep apnoea patients, who were studied in a sub-group as part of the ongoing "NeuRA Sydney study".

Read Full Article

Oventus Medical Ltd (ASX:OVN) Airway Technology Achieves Positive Clinical Trial

🕔5/22/2018 10:21:38 AM 2020

Oventus Medical Ltd (ASX:OVN) is pleased to announce the results of the OVEN-003 clinical trial study being conducted in Brisbane by the company, a randomised controlled clinical trial examining the treatment outcomes of oral appliance therapy with and without 'Oventus Airway Technology'.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Quarterly Business Review

🕔4/23/2018 9:29:36 AM 2461

Oventus Medical Ltd (ASX:OVN) announces its Appendix 4C Report for the three-month period ending 31 March 2018 (Q3 FY2018) and is pleased to provide a review of progress made during the quarter.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Investor Presentation

🕔9/27/2017 8:23:33 AM 4273

Oventus Medical Ltd (ASX:OVN) provide the latest Investor Presentation.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Audited Financial Statements and Appendix 4E

🕔8/31/2017 1:27:22 PM 4786

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to release its Appendix 4E with its full year audited general purpose financial report for the period ending 30 June 2017.

Read Full Article

FINANCE VIDEO: Oventus Medical Ltd (ASX:OVN) Financial News Network Interview

🕔8/24/2017 10:00:45 AM 7964

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to share Dr Chris Hart's interview on Financial News Network.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Appendix 4C - Quarterly Cash Flow Report

🕔7/31/2017 9:45:46 AM 4362

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has today released its Appendix 4C - Quarterly cash flow report for the period ended 30 June 2017.

Read Full Article
###

12,830 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 71) (Last 30 Days: 440) (Since Published: 12830) 

Markets ASX:OVN

Company Data

    Headquarters
  • 1 Swann Road
    Indooroopilly
    PO Box 190, Indooroopilly
    4068 QLD Australia
  • Telephone
  • 1300 533 159 
  • Principal Sector
  • Chemical Equipment & Manufacturing 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.oventus.com.au

Company Reports

Presentations

Quarterly Report

Social Media